These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure. Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159 [TBL] [Abstract][Full Text] [Related]
10. Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure. Hotta T; Ogawa H; Saito A; Ito A Int J Hematol; 1991 Jun; 54(3):195-200. PubMed ID: 1747454 [TBL] [Abstract][Full Text] [Related]
11. [Erythropoietin in 1991--pathophysiological and therapeutic aspects]. Wiecek A Przegl Lek; 1992; 49(1-2):31-5. PubMed ID: 1455002 [No Abstract] [Full Text] [Related]
12. [Review of the scientific evidence of the efficiency of erythropoietin use]. García-Altés A; Puig-Junoy J Med Clin (Barc); 2006 Sep; 127(11):415-20. PubMed ID: 17020686 [No Abstract] [Full Text] [Related]
13. Erythropoietin: from molecular biology to clinical use. Lacombe C Eur Cytokine Netw; 1997 Sep; 8(3):308-10. PubMed ID: 9346370 [No Abstract] [Full Text] [Related]
14. [Chemical structure, biotechnical production and clinical use of recombinant erythropoietin]. Fandrey JK; Jelkmann WE Z Gesamte Inn Med; 1992 Jun; 47(6):231-8. PubMed ID: 1642021 [TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human erythropoietin on sodium balance in nondialysed children with chronic renal failure. Kavukçu S; Saatci U; Ciliv G; Söylemezoğlu O; Bakkaloğlu A; Besbas N; Ozen S Int Urol Nephrol; 1993; 25(6):611-5. PubMed ID: 8175282 [TBL] [Abstract][Full Text] [Related]
16. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics. Tagawa H; Nagano M; Saito H; Umezu M; Yamakado M Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294 [TBL] [Abstract][Full Text] [Related]
17. [Molecular biology in regulation of kidney functions: Erythropoietin]. Tsubakihara Y Nihon Rinsho; 2006 Feb; 64 Suppl 2():327-31. PubMed ID: 16523911 [No Abstract] [Full Text] [Related]
18. Nucleotide and glutathione status in erythrocytes of children undergoing chronic hemodialysis under erythropoietin treatment. Sachs G; Siems W; Grune T; Schmidt G; Gerber G; Zoellner K Biomed Biochim Acta; 1990; 49(2-3):S123-4. PubMed ID: 2386496 [TBL] [Abstract][Full Text] [Related]
19. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report. Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336 [TBL] [Abstract][Full Text] [Related]
20. [Erythropoietin: its biological properties and clinical use]. Ermolenko VM; Nikolaev AIu Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979 [No Abstract] [Full Text] [Related] [Next] [New Search]